Good research practices for measuring drug costs in cost-effectiveness analyses: an international perspective: the ISPOR Drug Cost Task Force report–Part VI

/ 2010, CIESP, Health Technology Assessment, Scientific Publications / By

LZ Shi,M. Hodges,M. Drummond, J. Ahn,SC Li,SL Hu,F. Augustovski, JW Hay and J. Smeeding. Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyzes: An International Perspective: The ISPOR Drug Cost Task Force Report-Part VI. Value in Health. 2010;13(1):10.1111/j.1524-4733.2009.00662.x.

Go to publication